Levelling the playing field through the London Network of the UK clinical trials accelerator platform
Cystic fibrosis (CF) is a multisystem, genetic disease with a significantly reduced life expectancy. Despite substantial progress in therapies in the last 10–15 years, there is still no cure. There are dozens of drugs in the development pipeline and multiple clinical trials are being conducted acros...
Guardat en:
| Autors principals: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2024-06-01
|
| Col·lecció: | Contemporary Clinical Trials Communications |
| Accés en línia: | http://www.sciencedirect.com/science/article/pii/S2451865424000486 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
